UNNE

Catálogo Bibliográfico
Red de Bibliotecas UNNE

Red de Bibliotecas
Ouchi, Kentaro
  El número y tipo de antiepilépticos afectan el requerimiento de dosis de propofol para la anestesia: estudio observacional.
  En: Odontology / The Society of the Nippon Dental University; odo, v.108 no 1. -- Vol. 108, no. 1 (January, 2020). -- Tokyo : Springer, 2001

  The propofol dose requirement and the emergence time are affected by antiepileptic use. The effects on anesthesia of the number and kind of antiepileptic agents have not been reported. We investigated the relationship between the kind and number of antiepileptic agents and the propofol dose requirement for anesthesia and emergence time in intravenous general anesthesia for dental treatment for patients with neurological disorders. We studied 247 patients with neurological disorders who underwent dental treatment under intravenous general anesthesia. Patients were categorized according to the number of antiepileptics (none, single agent, two kinds, and three or more kinds of antiepileptics) and the kind of antiepileptic (carbamazepine, valproate, phenobarbital, phenytoin, zonisamide, clobazam, or topiramate) being received. The propofol dose requirement for anesthesia, emergence time, and predicted blood propofol concentration at emergence were evaluated. Patients on three or more kinds of antiepileptics had significantly lower propofol dose requirement (reduction in 25%, compare with no use) and predicted blood propofol concentration at emergence (reduction in 41%) and significantly longer emergence time (extension in 50%) (P?<?0.05). Valproate and clobazam reduced the propofol dose (valproate 9% and clobazam 19%) and predicted blood propofol concentration at emergence (valproate 18% and clobazam 33%), while phenobarbital increased these parameters (30% and 125%) (P?<?0.05). The number and kind of antiepileptics effects propofol dose requirement. In particular, valproate and clobazam reduce the propofol dose requirement, while phenobarbital increases this.
  ISSN: 16181247

  1. ANESTESICOS; 2. PROPOFOL; 3. DESORDEN NEUROLÒGICO; 4. DOSIS DE PROPOFOL; 5. TRATAMIENTO DENTAL; 6. ANESTESIA GENERAL INTRAVENOSA; 7. MEDULA SUPRARRENAL; 8. ANTIEPILECTICOS

Dirección: Av. Las Heras 727
Campus UNNE Resistencia, Chaco. CP 3500.
E-Mail: contacto@bib.unne.edu.ar
Nos encontramos dando servicios
únicamente en forma virtual

Formulario para Solicitud de Material

Ouchi, Kentaro
El número y tipo de antiepilépticos afectan el requerimiento de dosis de propofol para la anestesia: estudio observacional.
En: Odontology / The Society of the Nippon Dental University; odo, v.108 no 1. -- Vol. 108, no. 1 (January, 2020). -- Tokyo : Springer, 2001

The propofol dose requirement and the emergence time are affected by antiepileptic use. The effects on anesthesia of the number and kind of antiepileptic agents have not been reported. We investigated the relationship between the kind and number of antiepileptic agents and the propofol dose requirement for anesthesia and emergence time in intravenous general anesthesia for dental treatment for patients with neurological disorders. We studied 247 patients with neurological disorders who underwent dental treatment under intravenous general anesthesia. Patients were categorized according to the number of antiepileptics (none, single agent, two kinds, and three or more kinds of antiepileptics) and the kind of antiepileptic (carbamazepine, valproate, phenobarbital, phenytoin, zonisamide, clobazam, or topiramate) being received. The propofol dose requirement for anesthesia, emergence time, and predicted blood propofol concentration at emergence were evaluated. Patients on three or more kinds of antiepileptics had significantly lower propofol dose requirement (reduction in 25%, compare with no use) and predicted blood propofol concentration at emergence (reduction in 41%) and significantly longer emergence time (extension in 50%) (P? ISSN: 16181247

1. ANESTESICOS; 2. PROPOFOL; 3. DESORDEN NEUROLÒGICO; 4. DOSIS DE PROPOFOL; 5. TRATAMIENTO DENTAL; 6. ANESTESIA GENERAL INTRAVENOSA; 7. MEDULA SUPRARRENAL; 8. ANTIEPILECTICOS
Solicitante: